BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18310801)

  • 21. Pneumococcal vaccination guidelines.
    Schroeder SD
    S D Med; 2006 Jan; 59(1):19. PubMed ID: 16610467
    [No Abstract]   [Full Text] [Related]  

  • 22. [Splenectomy and pneumococcal vaccination].
    van Haecht CH
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1141. PubMed ID: 12822526
    [No Abstract]   [Full Text] [Related]  

  • 23. Pneumococcal vaccination in developing countries: where does science end and commerce begin?
    Mathew JL
    Vaccine; 2009 Jul; 27(32):4247-51. PubMed ID: 19389448
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduction in the incidence of invasive pneumococcal disease after general vaccination with 7-valent pneumococcal conjugate vaccine in Germany.
    Rückinger S; van der Linden M; Reinert RR; von Kries R; Burckhardt F; Siedler A
    Vaccine; 2009 Jun; 27(31):4136-41. PubMed ID: 19406190
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Response to commentaries.
    Light DW
    Hum Vaccin; 2011 May; 7(5):496. PubMed ID: 21552005
    [No Abstract]   [Full Text] [Related]  

  • 26. [The importance of pneumococcal vaccination - a clinician's view].
    Havlík J
    Klin Mikrobiol Infekc Lek; 2008 Feb; 14(1):30, 32-5. PubMed ID: 18327738
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Splenectomy and pneumococcal vaccination].
    Hoepelman IM; Wolfs TF
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1143; author reply 1143. PubMed ID: 12822530
    [No Abstract]   [Full Text] [Related]  

  • 28. Preventing pneumococcal disease.
    Dobkin JF
    AIDS Read; 2006 Feb; 16(2):81-2. PubMed ID: 16471273
    [No Abstract]   [Full Text] [Related]  

  • 29. Effectiveness of a 2+1 dose schedule pneumococcal conjugate vaccination programme on invasive pneumococcal disease among children in Norway.
    Vestrheim DF; Løvoll O; Aaberge IS; Caugant DA; Høiby EA; Bakke H; Bergsaker MR
    Vaccine; 2008 Jun; 26(26):3277-81. PubMed ID: 18456376
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute epiglottitis now affecting adults is mostly caused by pneumococci. Important to observe the incidence when considering future vaccination strategy].
    Isakson M; Hugosson S
    Lakartidningen; 2007 Nov 21-27; 104(47):3531-3. PubMed ID: 18203585
    [No Abstract]   [Full Text] [Related]  

  • 31. [Splenectomy and pneumococcal vaccination].
    Kroon FP; van Dissel JT
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1143; author reply 1143. PubMed ID: 12822529
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibiotic resistance in Latin America: a cause for alarm.
    Valenzuela MT; de Quadros C
    Vaccine; 2009 Aug; 27 Suppl 3():C25-8. PubMed ID: 19540634
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Progress in vaccines, progress in health economics.
    Annemans L
    Vaccine; 2010 Nov; 28 Suppl 6():G1-2. PubMed ID: 21075264
    [No Abstract]   [Full Text] [Related]  

  • 34. [Infant dies of invasive pneumococcal disease].
    Sitzmann FC
    Klin Padiatr; 2005; 217(5):251-2. PubMed ID: 16167270
    [No Abstract]   [Full Text] [Related]  

  • 35. Changing epidemiology of invasive pneumococcal disease: a complicated story.
    Black S
    Clin Infect Dis; 2008 Aug; 47(4):485-6. PubMed ID: 18627248
    [No Abstract]   [Full Text] [Related]  

  • 36. [Splenectomy and pneumococcal vaccination].
    Jeurissen A
    Ned Tijdschr Geneeskd; 2003 Jun; 147(23):1142-3; author reply 1143. PubMed ID: 12822528
    [No Abstract]   [Full Text] [Related]  

  • 37. Do Indian children need pneumococcal vaccination?
    Srivastava RN
    Indian Pediatr; 2007 Oct; 44(10):791; author reply 791-2. PubMed ID: 17998585
    [No Abstract]   [Full Text] [Related]  

  • 38. Changing epidemiology of invasive pneumococcal disease among White Mountain Apache persons in the era of the pneumococcal conjugate vaccine.
    Lacapa R; Bliss SJ; Larzelere-Hinton F; Eagle KJ; McGinty DJ; Parkinson AJ; Santosham M; Craig MJ; O'Brien KL
    Clin Infect Dis; 2008 Aug; 47(4):476-84. PubMed ID: 18627249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Experience with pneumococcal conjugate vaccine in Norway.
    Aaberge IS
    Expert Rev Vaccines; 2009 Feb; 8(2):159-65. PubMed ID: 19196196
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cost-effectiveness analysis of a universal vaccination programme with the 7-valent pneumococcal conjugate vaccine (PCV-7) in Sweden.
    Bergman A; Hjelmgren J; Ortqvist A; Wisløff T; Kristiansen IS; Högberg LD; Persson KM; Persson U
    Scand J Infect Dis; 2008; 40(9):721-9. PubMed ID: 18712627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.